Brian Cogley
Fortune : 418 950 $ au 31/05/2026
Fortune : 418 950 $ au 31/05/2026
Brian Cogley is currently Chief Financial Officer at Coeptis Therapeutics, Inc. since 2023 and Chief Financial Officer at Z Squared, Inc. starting in 2026.
Former roles include Chief Financial Officer at Coeptis Therapeutics Holdings, Inc., Senior Manager-Accounting Advisory at Cfgi LLC, and Vice President-Finance & Accounting at NexTier Bank, NA from 2017 to 2022.
Education includes undergraduate and MBAistration degrees from Duquesne University of The Holy Spirit.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,09% | 27/04/2026 | 45 000 ( 0,09% ) | 418 950 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NAERODYNAMICS INC | Directeur Financier/CFO | 17/05/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
NexTier Bank, NA
NexTier Bank, NA Major BanksFinance Provides national banking solutions | Directeur Financier/CFO | 01/02/2022 |
| COEPTIS THERAPEUTICS | Directeur Financier/CFO | - |
Cfgi LLC /Privategroup/
Cfgi LLC /Privategroup/ Financial ConglomeratesFinance Acts as a private group led by CVC Advisors (US) Inc and management and existing investor of CFGI LLC | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies novel therapy products for cancer patients | Health Technology |
Duquesne University of The Holy Spirit
Duquesne University of The Holy Spirit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NexTier Bank, NA
NexTier Bank, NA Major BanksFinance Provides national banking solutions | Finance |
Cfgi LLC /Privategroup/
Cfgi LLC /Privategroup/ Financial ConglomeratesFinance Acts as a private group led by CVC Advisors (US) Inc and management and existing investor of CFGI LLC | Finance |
Coeptis Therapeutics Holdings, Inc.
Coeptis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national